OMDA — Omada Health stock price, charts and financials

QT54Omada Health

Omada Health (NASDAQ: OMDA) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.43
+0.60+3.03%
OverviewShort InterestFilings
OMDAQT54Omada Health·NASDAQ
20.43+3.03%
TA
Loading chart...
Signal & projected range
QT Score upgradeHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CERT-1.86%$8.42GDRX-0.59%$3.38TDOC+0.32%$6.30OMCL-1.20%$32.23HSTM+0.14%$29.23SOPH-3.99%$8.19PRVA-1.19%$19.85PHR-2.33%$10.04
Snapshot
Index-P/E-EPS (ttm)0.06Insider Own14.98%Shs Outstand59.45MPerf Week3.92%
Market Cap1.25BForward P/E45.78EPS next Y0.45Insider Trans-4.87%Shs Float4.57MPerf Month-16.51%
Enterprise Value1.02BPEG-EPS next Q0.09Inst Own-Short Float9.66%Perf Quarter15.82%
Income4.00MP/S3.92EPS this Y447.62%Inst Trans-Short Ratio4.52Perf Half Y46.66%
Sales310.00MP/B5.68EPS next Y35.82%ROA1.31%Short Interest5.74MPerf YTD29.47%
Book/sh3.60P/C5.45EPS next 5Y-ROE1.84%52W High26.92 -24.11%Perf Year-9.32%
Cash/sh3.75P/FCF51.36EPS past 3/5Y-ROIC-0.18%52W Low10.28 98.74%Perf 3Y-
Dividend Est.-EV/EBITDA85.13Sales past 3/5Y42.95% -Gross Margin68.19%Volatility4.44% 4.80%Perf 5Y-
Dividend TTM-EV/Sales3.30EPS Y/Y TTM107.06%Oper. Margin-0.15%ATR (14)1.13Perf 10Y-
Dividend Ex-Date-Quick Ratio3.85Sales Y/Y TTM82.35%Profit Margin1.39%RSI (14)41.50Recom2.15
Dividend Gr. 3/5Y-Current Ratio3.91EPS Q/Q266.67%SMA20-8.10%Beta1.15Target Price25.88
Payout0.00%Debt/Eq0.00Sales Q/Q44.26%SMA50-8.51%Rel Volume4.70Prev Close19.83
Employees946LT Debt/Eq0.46EarningsNov 05SMA20019.64%Avg Volume1.42MPrice20.43
IPO DateJun 06, 2025Option/ShortNo / YesEPS/Sales Surpr.141.16% 9.74%Net Debt/EBITDA-18.86Volume6,681,182Change3.03%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-11-26ReiteratedBarclaysOverweight$25 → $27
Aug-12-26ReiteratedRobert W. Baird$15 → $25
Aug-10-26ReiteratedBTIGBuy$30 → $35
Aug-07-26ReiteratedBMO CapitalOutperform$18 → $24
Aug-03-26ReiteratedBarclaysOverweight$22 → $25
Jul-21-26ReiteratedCanaccord GenuityBuy$24 → $28
Jul-17-26InitiatedBTIGBuy$30
Jun-22-26ReiteratedMorgan StanleyOverweight$32 → $30
May-08-26ReiteratedCanaccord GenuityBuy$22 → $24
May-08-26ReiteratedEvercore ISI GroupOutperform$15 → $20
Latest News· Times ET
Sep-11-26
Sep-11-2605:49AM
Barclays Maintains Overweight on Omada Health, Raises Price Target to $27Benzinga
12:17AM
Omada Health, Inc. (OMDA) Analyst/Investor Day Transcriptseekingalpha.com
Sep-10-26
Sep-10-2605:00AM
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Dayglobenewswire.com
Sep-09-26
Sep-09-2605:01AM
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Programglobenewswire.com
12:55AM
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Sharesfool.com
Sep-07-26
Sep-07-2610:51AM
Here's Why Teladoc's Integrated Care Business Deserves More AttentionYahoo
Sep-03-26
Sep-03-2612:01AM
Omada Health, Inc. (NASDAQ:OMDA) Receives $26.50 Average PT from Brokeragesdefenseworld.net
Sep-01-26
Sep-01-2605:11AM
Omada Health (NASDAQ:OMDA) Combines High Growth Momentum with Breakout SetupChartMill
12:13AM
2,222,074 Shares in Omada Health, Inc. $OMDA Bought by BlackRock Inc.defenseworld.net
Aug-26-26
Aug-26-2601:07PM
12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga
Aug-14-26
Aug-14-2608:08AM
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30Benzinga
Aug-12-26
Aug-12-2607:45AM
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earningsseekingalpha.com
Aug-11-26
Aug-11-2605:05AM
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategymarketbeat.com
Aug-10-26
Aug-10-2601:34AM
BTIG Maintains Buy on Omada Health, Raises Price Target to $35Benzinga
Aug-07-26
Aug-07-2604:01PM
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com
Company

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue310260170——
Cost of Goods Sold Incl. D&A988967——
Gross Profit212171103——
Selling, General and Administrative Excl. Other125142111——
Research and Development384136——
Other Operating Expense
4800——
Operating Income-1-12-44——
Interest Expense035——
Unusual Expense
—————
Non-Operating Income (Expense)621——
Net Income Before Taxes4-13-47——
Income Taxes
000——
Consolidated Net Income4-13-47——
Net Income From Continuing Operations4-13-47——
Net Income4-13-47——
EPS (Recurring)0.07-0.22-0.85——
EPS (Basic, Before Extraordinaries)0.07-0.22-0.85——
EPS (Diluted)0.06-0.22-0.85——
EBITDA12-5-38——
Other After Tax Adjustments
—————
Stock Option Compensation Expense
—————
Price To Earnings Ratio
340.50————
Price To Sales Ratio3.953.52———
Gross Margin68.3965.7760.59——
Operating Margin-0.32-4.62-25.88——
Net Margin1.29-5.00-27.65——
Shares Outstanding605856——
Market Capitalization1,226915———
Operating Lease Expense
—————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$29.16$24.01$18.86$13.71$8.56● Close Price0.00M1.16M2.31M3.47M4.62MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cook Steven L.Chief Financial OfficerSep 10 '26Sale21.866,800148,640173,906Sep 14
Duffy Sean P.Chief Executive OfficerSep 10 '26Sale21.8714,960327,197382,594Sep 14
Shao Wei-LiPresidentSep 10 '26Sale21.854,03688,206295,313Sep 14
Gracey CraigChief Accounting OfficerSep 09 '26Sale21.7364413,99514,412Sep 11
Duffy Sean P.Chief Executive OfficerSep 01 '26Option Exercise6.9821,572150,657433,433Sep 03
Duffy Sean P.Chief Executive OfficerSep 01 '26Sale23.6221,572509,465411,861Sep 03
Cook Steven L.Chief Financial OfficerAug 27 '26Sale25.001,10827,700187,209Aug 31
Cook Steven L.Chief Financial OfficerAug 27 '26Option Exercise8.281,1089,174188,317Aug 31
Shao Wei-LiPresidentAug 12 '26Sale25.028,866221,798307,372Aug 12
Cook Steven L.Chief Financial OfficerAug 11 '26Sale25.011,60740,197187,209Aug 12
Cook Steven L.Chief Financial OfficerAug 11 '26Option Exercise8.281,60713,306188,816Aug 12
Cook Steven L.Chief Financial OfficerAug 10 '26Option Exercise8.2315,235125,448202,444Aug 12
Cook Steven L.Chief Financial OfficerAug 10 '26Sale25.0315,235381,350187,209Aug 12
Gracey CraigChief Accounting OfficerAug 10 '26Option Exercise6.571,0426,84616,483Aug 12
Gracey CraigChief Accounting OfficerAug 10 '26Sale25.001,04226,05015,441Aug 12
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.